Call Text Chat Email Refer a Patient Join a Study

Search

MotherToBaby

Medications and More during pregnancy and breastfeeding

Berberine

Selected References:  

  • An Y, et al. 2014. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf), 80(3):425-431.  
  • Chan E. 1993. Displacement of bilirubin from albumin by berberine. Biol Neonate, 63:201-208. 
  • Di Pierro F, et al. 2023. Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial. Frontiers in pharmacology, 14:1269605. 
  • Ha S & Song X. 2024. Berberine as adjuvant therapy for treating reduced fertility potential in women with polycystic ovary syndrome: A meta-analysis of randomized controlled trials. Explore (New York, N.Y.), 20(6):103040 
  • Imanshahidi M, et al. 2008. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res, 22:999–1012. 
  • Lampe KF. 1999. Berberine. In DeSmet PAGM, Keller K, Hnsel R, Chandler RF. Adverse effects of herbal drugs, vol 1: 97-103. Springer-Verlag, Berlin. 
  • Zhao S, et al. 2021. Effect and mechanism of berberine against polycystic ovary syndrome. Biomedicine & Pharmacotherapy, 138:111468. 

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.